Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.

Abstract excerpt

Since the discovery of activating mutations in JAK2 in patients with myeloproliferative neoplasms (MPNs) in 2005, gene discovery efforts have identified additional disease alleles, which can predate or occur subsequent to acquisition of JAK2/MPL mutations. In 2009, somatic copy number loss and mutations in the genes TET2 and ASXL1 were identified in MPN patients. Genetic analysis of MPN patient cohorts with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dioxygenases
• Share to DNA-Binding Proteins
• Share to MPL gene